vs
Side-by-side financial comparison of Dominari Holdings Inc. (DOMH) and GERON CORP (GERN). Click either name above to swap in a different company.
GERON CORP is the larger business by last-quarter revenue ($47.2M vs $30.1M, roughly 1.6× Dominari Holdings Inc.). GERON CORP runs the higher net margin — -39.0% vs -438.1%, a 399.1% gap on every dollar of revenue. On growth, Dominari Holdings Inc. posted the faster year-over-year revenue change (220.4% vs 67.1%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 369.1%).
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
DOMH vs GERN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.1M | $47.2M |
| Net Profit | $-131.8M | $-18.4M |
| Gross Margin | — | — |
| Operating Margin | -8.9% | -29.4% |
| Net Margin | -438.1% | -39.0% |
| Revenue YoY | 220.4% | 67.1% |
| Net Profit YoY | -12426.2% | 30.3% |
| EPS (diluted) | $-6.94 | $-0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.1M | — | ||
| Q3 25 | $50.8M | $47.2M | ||
| Q2 25 | $34.1M | $49.0M | ||
| Q1 25 | $8.1M | $39.6M | ||
| Q4 24 | $9.4M | — | ||
| Q3 24 | $4.0M | $28.3M | ||
| Q2 24 | $6.2M | $882.0K | ||
| Q1 24 | $1.4M | $304.0K |
| Q4 25 | $-131.8M | — | ||
| Q3 25 | $125.2M | $-18.4M | ||
| Q2 25 | $16.6M | $-16.4M | ||
| Q1 25 | $-32.5M | $-19.8M | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $-4.2M | $-26.4M | ||
| Q2 24 | $-6.1M | $-67.4M | ||
| Q1 24 | $-5.4M | $-55.4M |
| Q4 25 | -8.9% | — | ||
| Q3 25 | -3.1% | -29.4% | ||
| Q2 25 | -57.0% | -25.4% | ||
| Q1 25 | -394.6% | -42.2% | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | -79.1% | -99.8% | ||
| Q2 24 | -44.3% | -7860.9% | ||
| Q1 24 | -205.2% | -18465.1% |
| Q4 25 | -438.1% | — | ||
| Q3 25 | 246.4% | -39.0% | ||
| Q2 25 | 48.7% | -33.4% | ||
| Q1 25 | -400.5% | -50.1% | ||
| Q4 24 | 11.4% | — | ||
| Q3 24 | -104.2% | -93.5% | ||
| Q2 24 | -99.1% | -7639.8% | ||
| Q1 24 | -398.0% | -18220.4% |
| Q4 25 | $-6.94 | — | ||
| Q3 25 | $7.27 | $-0.03 | ||
| Q2 25 | $1.12 | $-0.02 | ||
| Q1 25 | $-3.02 | $-0.03 | ||
| Q4 24 | $0.21 | — | ||
| Q3 24 | $-0.67 | $-0.04 | ||
| Q2 24 | $-1.01 | $-0.10 | ||
| Q1 24 | $-0.91 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.5M | $78.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $69.4M | $248.7M |
| Total Assets | $112.9M | $567.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.5M | — | ||
| Q3 25 | $176.2M | $78.1M | ||
| Q2 25 | $28.2M | $77.7M | ||
| Q1 25 | $18.9M | $83.7M | ||
| Q4 24 | $8.2M | — | ||
| Q3 24 | $7.2M | $60.3M | ||
| Q2 24 | $12.1M | $116.9M | ||
| Q1 24 | $7.1M | $189.8M |
| Q4 25 | $69.4M | — | ||
| Q3 25 | $210.2M | $248.7M | ||
| Q2 25 | $88.6M | $259.5M | ||
| Q1 25 | $42.4M | $268.2M | ||
| Q4 24 | $39.9M | — | ||
| Q3 24 | $38.3M | $292.3M | ||
| Q2 24 | $42.4M | $306.7M | ||
| Q1 24 | $47.7M | $344.9M |
| Q4 25 | $112.9M | — | ||
| Q3 25 | $223.4M | $567.4M | ||
| Q2 25 | $109.3M | $555.2M | ||
| Q1 25 | $52.3M | $562.5M | ||
| Q4 24 | $47.1M | — | ||
| Q3 24 | $43.4M | $444.9M | ||
| Q2 24 | $49.1M | $449.4M | ||
| Q1 24 | $52.2M | $482.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $22.7M | $-13.6M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.7M | — | ||
| Q3 25 | $-4.9M | $-13.6M | ||
| Q2 25 | $-353.0K | $-27.4M | ||
| Q1 25 | $1.2M | $-48.0M | ||
| Q4 24 | $-16.7M | — | ||
| Q3 24 | $-4.7M | $-58.9M | ||
| Q2 24 | $1.4M | $-53.5M | ||
| Q1 24 | $-8.6M | $-62.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-53.7M | ||
| Q1 24 | — | $-62.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -6086.6% | ||
| Q1 24 | — | -20680.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 23.4% | ||
| Q1 24 | — | 202.3% |
| Q4 25 | — | — | ||
| Q3 25 | -0.04× | — | ||
| Q2 25 | -0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -15.65× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
GERN
Segment breakdown not available.
